Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and pseudomonas exotoxin

Molecular Medicine

Volumn 3, Issue 5, 1997, Pages 327-338

  Husain, Syed R ^a   Gill, Parkash ^b   Kreitman, Robert J ^c   Pastan, Ira ^c   Puri, Raj K ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; INTERLEUKIN 4 RECEPTOR; PSEUDOMONAS EXOTOXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; ISOTOPE LABELING; KAPOSI SARCOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030834337     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401811     Document Type: Article

References (54)

1. Freidman-Kien AE (1981) Disseminated Kaposi's sarcoma syndrome in young homosexual men. J. Am. Acad. Dermatol. 5: 468-471.
2. Gill PS (1991) Pathogenesis of AIDS related malignancies. Curr. Opin. Oncol. 3: 867-871.
3. Arms J (1989) A review of Kaposi's sarcoma. Adv. Cancer Res. 53: 73-87.
4. Werner S, Hofschneider PH, Roth WK (1984) Int. J. Cancer 43: 1137-1144.
5. Corbeil J, Evans LA, Vasak E, Cooper DA, Ronald P (1991) Culture and properties of cells derived from Kaposi's sarcoma. J. Immunol. 146: 2972-2976.
6. Ensoli B, Barillari G, Gallo RC (1991) Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematol. Oncol. Clin. N. Am. 5: 281-295.
7. Ganem D (1995) Virus, cytokines and Kaposi's sarcoma. AIDS 5: 469-471.
8. Ensoli B, Gallo RC (1992) Growth factors in AIDS-associated Kaposi's sarcoma: Cytokines and HIV-1 Tat protein. AIDS Updates 5: 1-7.
9. Miles SA (1994) Pathogenesis of HIV-related Kaposi's sarcoma. Curr. Opin. Oncol. 6: 497-502.
10. Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH (1992) Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi's sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc. Natl. Acad. Sci. U.S.A. 89: 7046-7050.
11. Pistritto G, Ventura L, Mores N, Lacal PM, D'Onfrio C (1994) Regulation of PDGF-B and PDGF receptor expression in the pathogenesis of Kaposi's sarcoma in AIDS. In: Giraldo G, Salvatore M, Bianchi LC, Giraldo EB, (eds) Diagn. Treat. AIDS Oncol. Adv. Tech. Res. 46: 73-87.
12. Hermans P, Gori A, Lemone M, Franchioly P, Clumeck N (1994) Possible role of granulocyte-macrophage colony stimulating factor (GM-CSF) on the rapid progression of AIDS-related Kaposi's sarcoma lesions in vivo. Br. J. Haematol. 87: 413-414.
13. Murakami-Mori K, Taga T, Kishimoto T, Nakamura S (1995) AIDS-associated Kaposi's sarcoma (KS) cells express oncastatin-M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. J. Clin. Invest. 96: 1319-1327.
14. Ensoli B, Nakamura S, Salahuddin SZ, et al. (1989) AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth factors. Science 243: 223-226.
15. Paul WE (1991) Interleukin 4: A prototypic immunoregulatory lymphokine. Blood 77: 859-1870.
16. Puri RK, Siegel JP (1993) Interleukin-4 and cancer therapy. Cancer Invest. 11: 473-486.
17. Puri RK (1995) Structure and functions of interleukin 4 and its receptors. In: Kurzock R, Talpaz M. (eds) Cytokines: Interleukins and Their Receptors. Kluwer Academic Publishers, Norwell, MA, pp. 143-185.
18. Obiri NI, Hillman GG, Haas GP, Sudha S, Puri RK (1993) Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin 4. J. Clin. Invest. 91: 83-89.
19. Obiri NI, Siegel JP, Varricchio F, Puri RK (1994) Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin. Exp. Immunol. 95: 148-155.
20. Taylor CW, Crogan TM, Salmon SE (1990) Effects of IL-4 on the in vitro growth of human lymphoid and plasma cell neoplasm. Blood 75: 1114-1118.
21. Herrmann F, Andreeff M, Gruss HJ, Brach MA, Lubbert M, Martelsmann R (1991) Interleukin-4 inhibits growth of multiple myeloma by suppressing IL-6 expression. Blood 78: 2070-2074.
22. Toi M, Bicknell R, Harris AL (1992) Inhibition of colon and breast carcinoma cell growth by interleukin 4. Cancer Res. 52: 275-279.
23. Clerici M, Hakim FT, Venzom DJ, et al. (1993) Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 93: 759-765.
24. Park LS, Friend D, Sassenfeld HM (1987) Characterization of human B cell stimulatory factor 1 receptor. J. Exp. Med. 166: 476-488.
25. Ohara J (1989) Interleukin 4: Molecular structure and biochemical characteristics, biological function and receptor expression. In Cruse JM, Lewis Jr. RE (eds) The Year in Immunology. Immunoregulatory Cytokines and Cell Growth. Basil Karger, pp 126-159.
26. Murata T, Noguchi PD, Puri RK (1995) Receptors for interleukin (IL)-4 do not associate with the common γ chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem. 270: 30829-30836.
27. Kreitman RJ, Puri RK, Pastan I (1995) Increase antitumor activity of circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma. Cancer Res. 55: 3357-3363.
28. Puri RK, Leland P, Obiri NI, et al. (1996) An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Cell. Immunol. 171: 80-86.
29. Kreitman RJ, Puri RK, Pastan I (1994). A circularly permuted recombinant interleukin 4 toxin with increased activity. Proc. Natl. Acad. Sci. U.S.A. 91: 6889-6893.
30. Puri RK, Debinski W, Obiri NI, Kreitman R, Pastan I (1994) Human renal cell carcinoma are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin. Cell. Immunol. 154: 369-379.
31. Puri RK, Leland P, Kreitman RJ, Pastan I (1994) Human neurological cancer cell express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4 Pseudomonas exotoxin chimeric protein. Int. J. Cancer 58: 574-581.
32. Debinski W, Puri RK, Kreitman RJ, Pastan I (1993) A wide range of human cancers express interleukin 4 (IL-4) receptors that can be targeted with chimeric toxin composed of IL-4 and Pseudomonas exotoxin. J. Biol. Chem. 268: 14065-14070.
33. Debinski W, Puri RK, Pastan I (1994) Interleukin-4 receptors expressed on tumors may serve as target for anticancer therapy using chimeric Pseudomonas exotoxin. Int. J. Cancer 58: 744-748.
34. Masood R, Husain SR, Rahman A, Gill P (1993) Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res. Hum. Retroviruses 8: 741-746.
35. Obiri NI, Debinski W, Leonard WJ, Puri RK (1995) Receptors for interleukin 13: Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukin 2, 4, 7, 9 and 15. J. Biol. Chem. 270: 8797-8804.
36. Reinecker HC, Podolsky DK (1995) Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma C chain of the interleukin 2 receptor. Proc. Natl. Acad. Sci. U.S.A. 92: 8353-8357.
37. Yoshida D, Piepmeier J, Weinstein M (1994) Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res. 54: 1415-1417.
38. Puri RK, Leland P, Obiri NI, et al. (1996) Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin. Blood 87: 4333-4339.
39. Munson PJ, Rodbard D (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239.
40. Zurawski SM, Vega F, Hughe B, Zurawski G (1993) Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that function in signal transduction. EMBO J. 12: 2663-2670.
41. Obiri NI, Leland P, Murata T, Debinski W, Puri RK (1997) The interleukin 13 receptor structure differs on various cell types and may share more than one component with interleukin 4 receptor. J. Immunol. 158: 756-764.
42. Keegan AD, Beckman MP, Park LS, Paul WE (1991) The IL-4 receptor: Biochemical characterization of IL-4 binding molecules in a T cell line expressing large number of receptors. J. Immunol. 146: 2272-2279.
43. Galizzi JP, Zuber CE, Cabrillat H, Djossou D, Banchereau J (1989) Internalization of human interleukin-4 and transient down regulation of its receptor in the CD23 inducible Jijoye cells. J. Biol. Chem. 264: 6984-6989.
44. Galizzi JP, Zuber CE, Cabrillat H, et al. (1990) Purification of 130 kDa T cell glycoprotein which binds human interleukin-4 with high affinity. J. Biol. Chem. 265: 439-444.
45. Foxwell BMJ, Woerly G, Ryffel B (1989) Identification of interleukin 4 receptor-associated proteins and expression of both high and low affinity binding on human lymphoid cells. Eur. J. Immunol. 19: 1637-1641.
46. Russell SM, Keegan AD, Harada N, et al. (1993) Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor. Science 262: 1880-1883.
47. Vita N, Lefort S, Laurent P, Caput D, Ferrara P (1995) Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 270: 3512-3517.
48. Noguchi M, Aldestein S, Cao X, Leonard W (1994) Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor. Science 263: 1453-1454.
49. Freedman VH, Shin SI (1974) Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359.
50. Mosley B, Beckmann P, March CJ, et al. (1989) The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane hound forms. Cell 59: 335-348.
51. Keegan AD, Nelms K, Wang L.-M, Pierce JH, Paul WE (1994) Interleukin 4 receptor: Signaling mechanism. Immunol. Today 15: 423-432.
52. Harada N, Yang G, Miyajima A, Howard M (1992) Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor. J. Biol. Chem. 267: 22752-22758.
53. Obiri NI, Puri RK (1994) Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cell. Oncol. Res. 6: 419-427.
54. Husain SR, Leland P, Aggarwal BB, Puri RK (1996) Transcriptional regulation of interleukin 4 receptors by human immunodeficiency virus type 1tat gene. AIDS Res. Hum. Retroviruses 12: 1349-1359.